Key points are not available for this paper at this time.
The use of low-dose TMP/SMX is associated with reduced risk of severe infections in patients with AAV treated with either RTX or CYC/AZA. Reduced B cell subpopulations at start of treatment might be a useful correlate of reduced immunocompetence.
Building similarity graph...
Analyzing shared references across papers
Loading...
Balazs Odler
Semmelweis University
Regina Riedl
Medical University of Graz
Philipp Gauckler
Innsbruck Medical University
Annals of the Rheumatic Diseases
Harvard University
Johns Hopkins University
University of Pennsylvania
Building similarity graph...
Analyzing shared references across papers
Loading...
Odler et al. (Thu,) studied this question.
synapsesocial.com/papers/69de9145353721b241b0c366 — DOI: https://doi.org/10.1136/ard-2022-223401
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: